Personalized blood tests for cancer using whole genome sequencing

Scientists have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-based blood tests, believed to be the first of their kind, may be used to monitor tumor levels after therapy and determine cancer recurrence.

Read the whole article on Science Daily

More from Science Daily